Derm In-Review welcomes our advertising supporters
Sonic Healthcare USA is a leading provider of state-of-the-art laboratory services and pathology practices throughout the USA. Offering customized dermatopathology services nationwide, Sonic Healthcare USA, Dermatopathology Division, is dedicated to providing exceptional support, unparalleled quality and a superior diagnosis. Our large team of board- certified dermatopathologists provide diagnostic expertise and work collaboratively with referring dermatologists and skincare providers to determine the best course of treatment for your patients. Our professional services include: accurate and expeditious dermatopathology results, resident, physician and patient educational resources, IT solutions and management tools designed to optimize practice workflow.
For more information, visit the Sonic Healthcare USA, Dermatopathology website at www.sonichealthcareusa.com/ap
At UCB, everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” We have a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe diseases of the immune system and the central nervous system. We do that by connecting with patients and their families around the world living with the physical and social burdens of severe disease. Those connections offer new perspectives, drive innovation, and offer the hope of a new generation of therapies that are helping to transform lives.
With a team of more than 7,500 employees and operations in 40 countries, we are a global biopharmaceutical company investing nearly 25% of revenue in cutting-edge scientific research to meet unmet patient needs. The company is based in Brussels, Belgium, with U.S. headquarters located in Atlanta, Georgia.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.